Paradigm Challenge / Biology

Cancer tumors maintain a diverse portfolio of cell types to protect themselves from extinction.

AI-generated illustration

The Takeaway

Darwinian theory suggests that the single strongest cancer cell should clone itself and take over the entire tumor. Cancers driven by extrachromosomal DNA instead maintain a continuous spectrum of genetic variety as a survival strategy. This deterministic bet-hedging ensures that at least some cells in the tumor will survive whatever treatment a doctor throws at them. The tumor acts more like an investment fund than a single predator, keeping a wide range of genetic options open at all times. This explains why many aggressive cancers bounce back so quickly after chemotherapy appears to work.

By SeriesFusion Editorial Board · May 4, 2026

Original Paper

Extrachromosomal DNA Gives Cancer a New Evolutionary Pathway

Wang, Y.; Cope, O.; Chen, J.; Mehta, A.; Fleifel, D.; Ford, C.; Benhamie, P.; Haase, S.; Murrray, M.; Gulec, S.; Elston, T.; Spanheimer, P. M.; Tomblin, C. A.; Rojas, A.; Tate, T.; Slade, L.; Purvis, J.; Wang, J. R.; Dahl, J. M.; Wolff, S. C.; Cook, J.; Brunk, E. C.

bioRxiv · 2025.04.26.650733

From the abstract

During tumor progression, it has been assumed that individual cells that have acquired advantageous mutations overtake the population. Cancers driven by extrachromosomal DNA (ecDNA) do not follow this paradigm. Instead, these tumors have a spectrum of oncogene copy numbers across cells, and graded ecDNA variation may function as a form of bet-hedging that equips tumors with a broad range of phenotypes. Using imaging, single-cell multiomics, and multiplexed proteomics, we systematically character

Read the original paper →

← Back to today's papers